Papers
2
Total Citations
22
H-Index
2
About
Dr. Jianwei Lin is a pioneering figure in both surgical oncology and advanced robotics, bridging the gap between clinical medicine and engineering innovation. His primary research focuses on minimally invasive hepatic surgery for hepatocellular carcinoma (HCC) and the dynamic control of flexible robotic systems. Dr. Lin’s most impactful contribution is his landmark 2022 study comparing robotic versus laparoscopic major hepatectomy for HCC, which has garnered 19 citations and provides critical short-term outcome data that helps surgeons choose the optimal approach for complex liver resections. This work is instrumental in advancing robotic surgery’s role in oncology. In parallel, Dr. Lin has made significant strides in robotics engineering, as demonstrated by his 2019 paper on dynamic linear predictive optimization for flexible robot profiling. This research addresses the challenge of controlling airbag deformation in flexible robots under uncertain environmental conditions, proposing a novel nonlinear control strategy that improves precision and adaptability. By integrating clinical surgical outcomes with cutting-edge robotic control theory, Dr. Lin’s work has a dual impact: enhancing patient care in liver cancer treatment while pushing the boundaries of robotic manipulation. His interdisciplinary achievements make him a unique and valuable contributor to both fields.
Research Focus
Key Achievements
Top Papers
- 1
- 2